9-98306298-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005458.8(GABBR2):​c.2052C>T​(p.Pro684Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.165 in 1,613,292 control chromosomes in the GnomAD database, including 22,495 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2178 hom., cov: 33)
Exomes 𝑓: 0.16 ( 20317 hom. )

Consequence

GABBR2
NM_005458.8 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.14

Publications

16 publications found
Variant links:
Genes affected
GABBR2 (HGNC:4507): (gamma-aminobutyric acid type B receptor subunit 2) The multi-pass membrane protein encoded by this gene belongs to the G-protein coupled receptor 3 family and GABA-B receptor subfamily. The GABA-B receptors inhibit neuronal activity through G protein-coupled second-messenger systems, which regulate the release of neurotransmitters, and the activity of ion channels and adenylyl cyclase. This receptor subunit forms an active heterodimeric complex with GABA-B receptor subunit 1, neither of which is effective on its own. Allelic variants of this gene have been associated with nicotine dependence.[provided by RefSeq, Jan 2010]
GABBR2 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 59
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with poor language and loss of hand skills
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 9-98306298-G-A is Benign according to our data. Variant chr9-98306298-G-A is described in ClinVar as Benign. ClinVar VariationId is 1167956.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.14 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.2 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GABBR2NM_005458.8 linkc.2052C>T p.Pro684Pro synonymous_variant Exon 15 of 19 ENST00000259455.4 NP_005449.5 O75899H9NIL8
GABBR2XM_017015331.3 linkc.1758C>T p.Pro586Pro synonymous_variant Exon 14 of 18 XP_016870820.1
GABBR2XM_005252316.6 linkc.1278C>T p.Pro426Pro synonymous_variant Exon 13 of 17 XP_005252373.1
GABBR2XM_017015332.3 linkc.1278C>T p.Pro426Pro synonymous_variant Exon 12 of 16 XP_016870821.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GABBR2ENST00000259455.4 linkc.2052C>T p.Pro684Pro synonymous_variant Exon 15 of 19 1 NM_005458.8 ENSP00000259455.2 O75899

Frequencies

GnomAD3 genomes
AF:
0.166
AC:
25174
AN:
152084
Hom.:
2181
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.171
Gnomad AMI
AF:
0.188
Gnomad AMR
AF:
0.191
Gnomad ASJ
AF:
0.131
Gnomad EAS
AF:
0.174
Gnomad SAS
AF:
0.212
Gnomad FIN
AF:
0.133
Gnomad MID
AF:
0.228
Gnomad NFE
AF:
0.158
Gnomad OTH
AF:
0.186
GnomAD2 exomes
AF:
0.170
AC:
42575
AN:
251022
AF XY:
0.172
show subpopulations
Gnomad AFR exome
AF:
0.172
Gnomad AMR exome
AF:
0.192
Gnomad ASJ exome
AF:
0.127
Gnomad EAS exome
AF:
0.166
Gnomad FIN exome
AF:
0.134
Gnomad NFE exome
AF:
0.160
Gnomad OTH exome
AF:
0.186
GnomAD4 exome
AF:
0.164
AC:
240257
AN:
1461090
Hom.:
20317
Cov.:
33
AF XY:
0.166
AC XY:
120679
AN XY:
726900
show subpopulations
African (AFR)
AF:
0.170
AC:
5675
AN:
33464
American (AMR)
AF:
0.193
AC:
8617
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.130
AC:
3398
AN:
26128
East Asian (EAS)
AF:
0.174
AC:
6920
AN:
39696
South Asian (SAS)
AF:
0.212
AC:
18289
AN:
86218
European-Finnish (FIN)
AF:
0.134
AC:
7132
AN:
53412
Middle Eastern (MID)
AF:
0.267
AC:
1538
AN:
5766
European-Non Finnish (NFE)
AF:
0.161
AC:
178396
AN:
1111350
Other (OTH)
AF:
0.170
AC:
10292
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
10694
21387
32081
42774
53468
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6528
13056
19584
26112
32640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.165
AC:
25177
AN:
152202
Hom.:
2178
Cov.:
33
AF XY:
0.165
AC XY:
12267
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.171
AC:
7108
AN:
41528
American (AMR)
AF:
0.191
AC:
2923
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.131
AC:
454
AN:
3470
East Asian (EAS)
AF:
0.173
AC:
896
AN:
5172
South Asian (SAS)
AF:
0.211
AC:
1017
AN:
4826
European-Finnish (FIN)
AF:
0.133
AC:
1413
AN:
10594
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.158
AC:
10738
AN:
68006
Other (OTH)
AF:
0.186
AC:
393
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1112
2224
3335
4447
5559
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.163
Hom.:
6232
Bravo
AF:
0.169
Asia WGS
AF:
0.169
AC:
588
AN:
3478
EpiCase
AF:
0.169
EpiControl
AF:
0.171

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Neurodevelopmental disorder with poor language and loss of hand skills Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epileptic encephalopathy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 59 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
1.3
DANN
Benign
0.77
PhyloP100
-2.1
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2304389; hg19: chr9-101068580; COSMIC: COSV52295707; COSMIC: COSV52295707; API